Form D · Pharmaceuticals
FibroBiologics, Inc.
Houston, TX · CIK 0001958777
Offering snapshot reported Sep 16, 2026 · SEC filing
- Reported sold
- $500K Offering amount: $500K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 15, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 16, 2026 | Initial | $500,001 | No comparison | 1 | SEC filing |
| Jun 29, 2026 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Dec 16, 2025 | Initial | $1,725,001 | No comparison | 4 | SEC filing |
| Dec 3, 2025 | Initial | $4,000,000 | No comparison | 1 | SEC filing |
| Dec 3, 2025 | Initial | $1,500,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-597605
Includes 298,508 shares of common stock and warrants to purchase common stock (exercise price of $1.55 per share), exercisable for up to 298,508 shares of common stock.
Source: Form D, filed Sep 16, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard C. Cilento | Director |
| Stacy Coen | Director |
| Jason D. Davis | Executive |
| Ruben A. Garcia | Executive |
| Robert Hoffman | Director |
| Hamid Khoja | Executive |
| Matthew Link | Director |
| Victoria Niklas | Director |
| Pete O'heeron | Director, Executive |
| Kathleen H. Rubins | Director |
| Leigh Steinberg | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
9350 Kirby Drive Suite 300
Houston, TX, 77054
Phone: 281-671-5150
Houston, TX, 77054
Phone: 281-671-5150